Impact of loss to follow-up on survival estimation for cystic fibrosis

被引:3
作者
Ostrenga, Joshua S. [1 ,3 ]
Brown, A. Whitney [1 ]
Todd, Jonathan, V [1 ]
Elbert, Alexander [1 ]
Fink, Aliza K. [2 ]
Faro, Albert [1 ]
Marshall, Bruce C. [1 ]
Cromwell, Elizabeth A. [1 ]
机构
[1] Cyst Fibrosis Fdn, Clin Affairs, Bethesda, MD USA
[2] Natl Org Rare Disorders, Res Programs, Washington, DC USA
[3] Cyst Fibrosis Fdn, Bethesda, MD 20814 USA
关键词
Cystic fibrosis; Registry data; Survival analysis; Loss to follow-up; DIAGNOSIS; GUIDELINES; ADULTS;
D O I
10.1016/j.annepidem.2023.07.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Deaths among those lost to follow-up (LTFU) in the Cystic Fibrosis Foundation Patient Registry (CFFPR) are critically important to the epidemiology of cystic fibrosis (CF). Unreported deaths could impact estimates of survival if LTFU is associated with disease trajectory.Methods: We characterized the LTFU population (1986-2017) from the CFFPR and identified deaths via linkage with the National Death Index (NDI). Median predicted survival age and conditional survival were estimated with and without additional deaths and person-time from the NDI.Results: Of the 10,582 individuals LTFU in the CFFPR, 2,460 (23.2%) matched to an NDI death record. Individuals who died after LTFU with a CF diagnosis were 43% female, 91% White/non-Hispanic, 59% had advanced CF lung disease based on last CFFPR recorded forced expiratory volume in one second (FEV1) %predicted < 40 and 18% were post-lung transplant. Median predicted survival age during the most recent period available, 2013-2017, increased from 44.3 years (95% CI: 43.2, 45.7) to 45.8 years (95% CI 44.5, 47.1) with the inclusion of NDI data.Conclusions: Inclusion of deaths and additional person-time among those LTFU changed the point estimate of median predicted survival for most time periods and increased the point estimate from 2009 onwards.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:98 / +
页数:11
相关论文
共 50 条
  • [21] The role of IDA scintigraphy in the follow-up of liver disease in patients with cystic fibrosis
    Foster, JA
    Ramsden, WH
    Conway, SP
    Taylor, JM
    Etherington, C
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (07) : 673 - 681
  • [22] Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients
    L. Spicuzza
    C. Sciuto
    G. Vitaliti
    G. Di Dio
    S. Leonardi
    M. La Rosa
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 191 - 195
  • [23] The role of advanced imaging techniques in cystic fibrosis follow-up: is there a place for MRI?
    Puderbach, Michael
    Eichinger, Monika
    PEDIATRIC RADIOLOGY, 2010, 40 (06) : 844 - 849
  • [24] Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
    Li, Shaoqiang
    Li, Ya
    Li, Zhengtu
    Yang, Xin
    Zhan, Yangqing
    Li, Weilong
    Lin, Ye
    Ye, Feng
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [25] Eosinophilic esophagitis in cystic fibrosis: A case series with long-term follow-up
    Mellor, Xochitl
    Schindler, Terri
    Saab, Shahrazad
    Roesch, Erica
    Sferra, Thomas
    Sankararaman, Senthilkumar
    PEDIATRIC PULMONOLOGY, 2022, 57 (06) : 1557 - 1561
  • [26] Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational study
    Brivio, Anna
    Orenti, Annalisa
    Barbisan, Mauro
    Buonpensiero, Paolo
    Ros, Mirco
    Gambazza, Simone
    MONALDI ARCHIVES FOR CHEST DISEASE, 2021, 91 (02)
  • [27] Laboratory biomarkers in the diagnosis and follow-up of treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis
    Steels, Sophie
    Proesmans, Marijke
    Bossuyt, Xavier
    Dupont, Lieven
    Frans, Glynis
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2023, 60 (01) : 1 - 24
  • [28] Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis
    Moran Lavie
    Tzipora Manovitz
    Daphna Vilozni
    Sarina Levy-Mendelovich
    Ifat Sarouk
    Ilana Weintraubv
    David Shoseyov
    Malena Cohen-Cymberknoh
    Joseph Rivlin
    Ori Efrati
    World Journal of Gastroenterology, 2015, 21 (01) : 318 - 325
  • [29] Is Impulse Oscillometry System a Useful Method for the Evaluation and Follow-Up of Patients with Cystic Fibrosis?
    Kartal Ozturk, Gokcen
    Eski, Aykut
    Gulen, Figen
    Demir, Esen
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2021, 34 (01) : 15 - 22
  • [30] Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis
    Adeboyeku, David
    Scott, Sandra
    Hodson, Margaret E.
    JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (04) : 261 - 263